A longitudinal study using data from the Alzheimer’s Disease Neuroimaging Initiative found that omega-3 fatty acid supplementation was associated with accelerated cognitive decline in older adults, challenging the common belief that omega-3 universally protects brain health. Participants taking omega-3 supplements showed faster worsening in MMSE, ADAS-Cog13, and CDR-SB scores over time. Interestingly, the association was not explained by classical Alzheimer’s disease pathologies such as amyloid-β accumulation, tau deposition, or gray matter atrophy. Instead, reduced cerebral glucose metabolism on FDG-PET scans—reflecting impaired synaptic and neuronal function in AD-vulnerable brain regions—partially mediated the relationship, accounting for 19% to 41% of the observed cognitive decline. These findings suggest that omega-3 supplementation may adversely affect cerebral synaptic function in some older adults and highlight the need for a more cautious reassessment of its widespread use for cognitive protection. Source: https://www.sciencedirect.com/
A meta-analysis of 15 randomized controlled trials involving 4,824 patients with high blood pressure found…
Higher levels of chronic systemic inflammation were associated with smaller left ventricular volumes, compensatory increases…
In patients with severe asymptomatic carotid artery stenosis, carotid revascularization—either carotid artery stenting (CAS) or…
A 2026 Cochrane systematic review and meta-analysis of 107 randomized trials involving 26,886 adults with…
Higher functional-connectivity-derived brain age deviation was consistently associated with poorer cognitive performance—particularly working memory and…
Higher nighttime light exposure was associated with adverse changes in cardiac structure and function and…
This website uses cookies.